Correlation Between Corvus Pharmaceuticals and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Lipella Pharmaceuticals.
Diversification Opportunities for Corvus Pharmaceuticals and Lipella Pharmaceuticals
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Corvus and Lipella is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Lipella Pharmaceuticals
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.65 times more return on investment than Lipella Pharmaceuticals. However, Corvus Pharmaceuticals is 1.54 times less risky than Lipella Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.01 per unit of risk. If you would invest 125.00 in Corvus Pharmaceuticals on November 27, 2024 and sell it today you would earn a total of 284.00 from holding Corvus Pharmaceuticals or generate 227.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Lipella Pharmaceuticals |
Corvus Pharmaceuticals and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Lipella Pharmaceuticals
The main advantage of trading using opposite Corvus Pharmaceuticals and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |